Pharmaceutical

Clearwater Publishes First-of-its-Kind Report Examining Cybersecurity Performance of Private Equity-Backed Portfolio Companies in Healthcare

New Benchmark Trend Data Identifies Potential Areas of Risk and Provides Recommended Actions to Protect and Create Portfolio Value NASHVILLE,…

10 months ago

Remedy Cell and Qureight collaborate to integrate deep learning platform into Phase 1b study of RC-0315 in IPF

HAIFA, Israel, and CAMBRIDGE, England, March 12, 2025 /PRNewswire/ -- Remedy Cell, a clinical-stage biopharmaceutical company focused on the development of…

10 months ago

Remedy Cell and Qureight collaborate to integrate deep learning platform into Phase 1b study of RC-0315 in IPF

HAIFA, Israel, and CAMBRIDGE, England, March 12, 2025 /PRNewswire/ -- Remedy Cell, a clinical-stage biopharmaceutical company focused on the development of…

10 months ago

Formedics Names Vincent Muehter as President to Lead Growth of HCP Collaboration Platform

BASKING RIDGE, N.J., March 12, 2025 /PRNewswire/ -- Formedics, a leading healthcare professional (HCP) collaboration platform, today announced that its…

10 months ago

datma Expands Federated Real-World Data Network Surpassing 1 Million Patient Lives with Multi omic and Pathology Data

BEAVERTON, Ore., March 12, 2025 /PRNewswire/ -- datma, a leader in federated real-world data access, today announced that its federated…

10 months ago

Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and a Cash Dividend

BEIJING, March 12, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated…

10 months ago

Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025

ROCKVILLE, Md. and SUZHOU, China, March 12, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical…

10 months ago

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

SCOTTSDALE, Ariz., March 12, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that…

10 months ago

Next-Gen Cancer Treatment: Rakovina’s AI-Driven ATR Inhibitors Enter Preclinical Testing

Harnessing generative AI to develop targeted therapies for DNA damage response, including hard-to-treat central nervous system malignanciesVANCOUVER, British Columbia, March…

10 months ago

Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward

Largest shareholder, CK Life Sciences Int’l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from…

10 months ago